Education
About Us
Working with TipRanks
Follow Us
OncoSec Medical (ONCSQ)
OTHER OTC:ONCSQ
Pembrolizumab, Nab Paclitaxel, Tavokinogene Telseplasmid, Immunopulse, Gemcitabine Plus Carboplatin
Triple Negative Breast Cancer
Phase II
Unknown
Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
Jun 13, 2018
―
Pembrolizumab, Tavokinogene Telseplasmid, Immunopulse
Stage Iii/Iv Melanoma
Phase II
Unknown
Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment
Apr 24, 2017
―
It-Pil12-Ep
Er-Negative Pr-Negative Her2-Negative Breast Cancer
Phase I
Completed
Evaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBC
Aug 18, 2015
―
Tavokinogene Telseplasmid (Tavo), Oncosec Medical System (Oms)
Head And Neck Squamous Cell Carcinoma
Phase II
Terminated
Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC)
Jan 19, 2015
―
Tavokinogene Telseplasmid (Tavo), Oncosec Medical System (Oms)
Cutaneous T Cell Lymphomas (Ctcl), Mycosis Fungoides (Mf)
Phase II
Terminated
Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma
Apr 15, 2012
―
Tavokinogene Telseplasmid (Tavo), Oncosec Medical System (Oms)
Melanoma
Phase II
Completed
Trial of pIL-12 Electroporation Malignant Melanoma
Dec 21, 2011
―
Tavokinogene Telseplasmid (Tavo), Oncosec Medical System (Oms)
Merkel Cell Carcinoma
Phase II
Completed
IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer
Sep 23, 2011
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does OncoSec Medical (ONCSQ) have in its pipeline
ONCSQ is currently developing the following drugs: Pembrolizumab, Nab Paclitaxel, Tavokinogene Telseplasmid, Immunopulse, Gemcitabine Plus Carboplatin, Pembrolizumab, Tavokinogene Telseplasmid, Immunopulse, It-Pil12-Ep. These drug candidates are in various stages of clinical development as the company works toward FDA approval.